Michael Ryskin
Stock Analyst at B of A Securities
(0.35)
# 2488
Out of 5,329 analysts
43
Total ratings
45.45%
Success rate
-6.83%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MRVI Maravai LifeSciences | Maintains: Buy | 9 8 | 2.08 | 284.62% | 3 | Mar 3, 2025 | |
TEM Tempus AI | Maintains: Neutral | 54 60 | 57.38 | 4.57% | 4 | Mar 3, 2025 | |
IDXX IDEXX Laboratories | Maintains: Neutral | 475 535 | 471.88 | 13.38% | 2 | Feb 4, 2025 | |
ALGN Align Tech | Maintains: Underperform | 200 206 | 179.67 | 14.65% | 6 | Dec 13, 2024 | |
GH Guardant Health | Maintains: Strong Buy | 28 40 | 47.56 | -15.9% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 10 | 5.32 | 78.57% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 9 | n/a | n/a | 2 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 13.09 | 83.35% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 12.9 | 86.05% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 25 | n/a | n/a | 2 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 225 180 | 157.71 | 14.13% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 90 | n/a | n/a | 3 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 52 | 25.47 | 104.16% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 17 10 | 3.06 | 226.8% | 2 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 10 7 | n/a | n/a | 2 | May 14, 2020 |